NO953557L - Antitumorpreparater og fremgangsmåte for deres fremstilling - Google Patents

Antitumorpreparater og fremgangsmåte for deres fremstilling

Info

Publication number
NO953557L
NO953557L NO953557A NO953557A NO953557L NO 953557 L NO953557 L NO 953557L NO 953557 A NO953557 A NO 953557A NO 953557 A NO953557 A NO 953557A NO 953557 L NO953557 L NO 953557L
Authority
NO
Norway
Prior art keywords
derivatives
methods
preparation
alkyl
hydrogen
Prior art date
Application number
NO953557A
Other languages
English (en)
Norwegian (no)
Other versions
NO953557D0 (no
Inventor
Gerald Burr Grundey
Cora Sue Grossman
James Jeffry Howbert
James Edward Ray
John Eldon Toth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO953557D0 publication Critical patent/NO953557D0/no
Publication of NO953557L publication Critical patent/NO953557L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO953557A 1993-03-10 1995-09-08 Antitumorpreparater og fremgangsmåte for deres fremstilling NO953557L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2909593A 1993-03-10 1993-03-10
PCT/US1994/002606 WO1994020101A1 (en) 1993-03-10 1994-03-10 Antitumor compositions and methods of treatment

Publications (2)

Publication Number Publication Date
NO953557D0 NO953557D0 (no) 1995-09-08
NO953557L true NO953557L (no) 1995-11-02

Family

ID=21847185

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953557A NO953557L (no) 1993-03-10 1995-09-08 Antitumorpreparater og fremgangsmåte for deres fremstilling

Country Status (20)

Country Link
EP (1) EP0614887B1 (cs)
JP (1) JPH08507532A (cs)
KR (1) KR960700710A (cs)
AT (1) ATE154345T1 (cs)
AU (1) AU687042B2 (cs)
BR (1) BR9405997A (cs)
CA (1) CA2157801A1 (cs)
CZ (1) CZ232695A3 (cs)
DE (1) DE69403695T2 (cs)
DK (1) DK0614887T3 (cs)
ES (1) ES2102774T3 (cs)
FI (1) FI954213L (cs)
GR (1) GR3023827T3 (cs)
HU (1) HU218660B (cs)
NO (1) NO953557L (cs)
NZ (1) NZ263080A (cs)
PL (1) PL310558A1 (cs)
RU (1) RU2127259C1 (cs)
WO (1) WO1994020101A1 (cs)
ZA (1) ZA941500B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU709107B2 (en) * 1996-08-22 1999-08-19 Dong Wha Pharmaceutical Industrial Co., Ltd. Arylsulfonylimidazolone derivatives as an antitumor agent
JP2000247949A (ja) * 1999-02-26 2000-09-12 Eisai Co Ltd スルホンアミド含有インドール化合物
DE19919793A1 (de) 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
DE60316984T2 (de) * 2002-11-22 2008-07-17 Eli Lilly And Co., Indianapolis Benzoylsulfonamide als antitumor-mittel
TWI315304B (en) * 2006-08-31 2009-10-01 Univ Taipei Medical Indoline-sulfonamides compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
NZ238911A (en) * 1990-07-17 1993-10-26 Lilly Co Eli Furyl, pyrrolyl and thienyl sulphonyl urea derivatives, pharmaceutical compositions and intermediates therefor
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
EP0614887A1 (en) 1994-09-14
BR9405997A (pt) 1995-12-19
AU6363894A (en) 1994-09-26
EP0614887B1 (en) 1997-06-11
FI954213A0 (fi) 1995-09-08
GR3023827T3 (en) 1997-09-30
HU218660B (hu) 2000-10-28
CZ232695A3 (en) 1996-01-17
ATE154345T1 (de) 1997-06-15
WO1994020101A1 (en) 1994-09-15
HUT72897A (en) 1996-06-28
HU9502627D0 (en) 1995-11-28
AU687042B2 (en) 1998-02-19
ZA941500B (en) 1995-09-04
RU2127259C1 (ru) 1999-03-10
FI954213A7 (fi) 1995-10-11
NZ263080A (en) 1996-12-20
CA2157801A1 (en) 1994-09-15
KR960700710A (ko) 1996-02-24
PL310558A1 (en) 1995-12-27
DE69403695D1 (de) 1997-07-17
DK0614887T3 (da) 1997-10-20
JPH08507532A (ja) 1996-08-13
FI954213L (fi) 1995-10-11
DE69403695T2 (de) 1997-10-30
NO953557D0 (no) 1995-09-08
ES2102774T3 (es) 1997-08-01

Similar Documents

Publication Publication Date Title
NO923466L (no) Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser
EP0328000A3 (de) Indolocarbazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
GEP20084357B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
DE60217118D1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
WO1991013055A3 (en) New aryl- and heteroarylethenylene derivatives and process for their preparation
CA2074853A1 (en) 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
FI890689A0 (fi) 3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
NO930891L (no) Nye diarylsulfonamider
CA2168097A1 (en) Substituted 2-aminotetralins
DK0783501T3 (da) Pyrimidonderivater med anti-fungal aktivitet
KR950011435A (ko) 이미다졸-4-일 피페리딘 유도체, 이것의 제법 및 이것의 치료에의 이용
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
ATE135348T1 (de) Pyrimidin-4-carboxamidderivate, ihre herstellung und ihre verwendung in der therapie
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
CA2244139A1 (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
CA2331141A1 (en) Water soluble azoles as broad-spectrum antifungals
NO20044810L (no) Farmasoytisk formulering med oyeblikkelig frigjoring
NO983178L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasaytisk preparat for behandling eller profylakse av menopausesymptomer
NO953557L (no) Antitumorpreparater og fremgangsmåte for deres fremstilling
NO891949L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser.
DK118083D0 (da) Theophyllinylalkyloxadiazoler eller additionssalte deraf, deres fremstilling og anvendelse som laegemidler